13. CVS Caremark and Cardinal Health create largest generic sourcing entity
in the U.S. – the world’s largest generic drug market
▪
Largest U.S. pharmacy health care provider
with over $120 billion in revenue
▪
Focused on enhancing access to care, lowering
overall health care costs, and improving health
outcomes
▪
▪
Filled >1 billion prescriptions last year through
its retail and mail order pharmacies
▪
▪
Leading health care services company with
$101 billion in revenue
Focused on improving the cost-effectiveness
and efficiency of health care so providers can
focus on their patients
Serve more than 100,000 locations daily
Sourcing Joint Venture
50/50 U.S.-based joint venture; largest generics sourcing entity in the U.S.
Combines deep sourcing expertise of two leading companies
Joint venture sources and negotiates generic supply contracts for both companies
Joint venture will not take ownership of products or hold inventory on behalf of either company
Will maintain CVS Caremark and Cardinal Health’s leadership positions as they drive value
for customers, clients and shareholders in a capital-efficient manner
Generic Manufacturers negotiate with Sourcing Joint Venture
New entity will collaborate with generic manufacturers to develop innovative supply chain and
purchasing strategies
Both CVS Caremark and Cardinal Health will continue to manage their product orders and
logistics processes in the same way as they do today
21. Cardinal Health, Inc. and Subs idiaries
GAAP / Non-GAAP Reconciliation
(in millions, except per common share amounts)
GAAP
Restructuring and employee severance
Amortization and other acquisition-related costs
Impairments and loss on disposal of assets
Litigation (recoveries)/charges, net
Other Spin-Of f costs
Gain on sale of CareFusion stock
Non-GAAP
Ope rating
Earnings
$
996
71
158
859
(38)
$
2,046
GAAP
Restructuring and employee severance
Amortization and other acquisition-related costs
Impairments and loss on disposal of assets
Litigation (recoveries)/charges, net
Other Spin-Of f costs
Gain on sale of CareFusion stock
Non-GAAP
$
GAAP
Restructuring and employee severance
Amortization and other acquisition-related costs
Impairments and loss on disposal of assets
Litigation (recoveries)/charges, net
Other Spin-Of f costs
Gain on sale of CareFusion stock
Non-GAAP
$
GAAP
Restructuring and employee severance
Amortization and other acquisition-related costs
Impairments and loss on disposal of assets
Litigation (recoveries)/charges, net
Other Spin-Of f Costs
Gain on sale of CareFusion stock
Non-GAAP
$
$
$
$
Fiscal Ye ar 2013
Ope rating
Earnings Before
Provision
Earnings
Earnings from Dilute d EPS
Dilute d EPS
Earnings
Incom e Taxes
for
from
Continuing
from
from Continuing
Grow th
and Discontinue d
Incom e
Continuing
Operations
Continuing
Operations
Rate
Operations
Taxes
Operations Grow th Rate 1 Ope rations
Grow th Rate 2
(44)% $
888 $
553 $
335
(69)% $
0.97
(68)%
71
27
44
0.13
158
52
106
0.31
859
37
822
2.39
(38)
(15)
(23)
(0.07)
10 % $
1,938 $
654 $
1,284
15 % $
3.73
16 %
1,792
21
33
21
(3)
2
1,866
18 % $
1,514
16
90
9
6
10
1,644
16 % $
1,307
91
18
29
(62)
11
1,394
13 % $
18 % $
1% $
(3)% $
1,698 $
21
33
21
(3)
2
1,772 $
Fiscal Year 2012
628 $
1,070
8
13
9
24
8
13
(1)
(2)
1
1
653 $
1,119
1,518 $
16
90
9
6
10
(75)
1,573 $
Fiscal Year 2011
552 $
966
5
10
22
68
3
6
(1)
7
4
6
(75)
585 $
988
1,212 $
91
18
29
(62)
53
(45)
1,296 $
Fiscal Year 2010
625 $
587
32
59
6
12
(5)
34
(23)
(39)
(149)
202
(45)
486 $
810
11 % $
13 % $
65 % $
22 % $
(23)% $
(2)% $
3.06
0.04
0.07
0.04
(0.01)
3.21
12 %
2.74
0.03
0.19
0.02
0.02
0.02
(0.21)
2.80
69 %
1.62
0.16
0.03
0.09
(0.11)
0.56
(0.12)
2.24
(23)%
15 %
25 %
(2)%
1
The 3-year compound annual grow th rate f or GAAP and non-GAAP earnings f rom continuing operations w as -9% and 14%, respectively.
2
The 3-year compound annual grow th rate f or GAAP and non-GAAP diluted EPS f rom continuing operations w as -16% and 19%, respectively. Excluding the $0.18 related to a favorable tax
settlement in Q3 FY13, the 3-year compound annual grow th rate for GAAP and non-GAAP diluted EPS from continuing operations w as -21% and 17%, respectively.
The sum of the components may not equal the total due to rounding.
21
We apply varying tax rates depending on the item’s nature and tax jurisdiction w here it is incurred.
22. Cardinal Health, Inc. and Subsidiaries
GAAP / Non-GAAP Reconciliation
(in millions, except per common share amounts)
GAAP
Restructuring and employee severance
Amortization and other acquisition-related costs
Impairments and loss on disposal of assets
Litigation (recoveries)/charges, net
Non-GAAP
GAAP
Restructuring and employee severance
Amortization and other acquisition-related costs
Impairments and loss on disposal of assets
Litigation (recoveries)/charges, net
Non-GAAP
Operating
Earnings
$
471
11
49
1
$
532
$
$
457
5
28
1
(22)
469
First Quarter 2014
Operating Earnings Before
Provision
Earnings Earnings from
Earnings
Incom e Taxes
for
from
Continuing
Grow th
and Discontinued
Incom e
Continuing
Operations
Rate
Operations
Taxes
Operations Grow th Rate
3% $
442 $
102 $
340
25 %
11
4
7
49
18
31
1
1
13 % $
503 $
124 $
378
35 %
11 % $
6% $
The sum of the components may not equal the total due to rounding.
We apply varying tax rates depending on the item’s nature and tax jurisdiction w here it is incurred.
22
439 $
5
28
1
(22)
451 $
First Quarter 2013
167 $
272
2
3
10
18
1
(9)
(13)
170 $
281
Diluted EPS
Diluted EPS
from
from Continuing
Continuing
Operations
Operations
Grow th Rate
$
0.99
25 %
0.02
0.09
$
1.10
36 %
15 % $
9% $
0.79
0.01
0.05
(0.04)
0.81
16 %
11 %
23. Cardinal Health, Inc. and Subsidiaries
GAAP / Non-GAAP Reconciliation
2013
Rolling Quarter
2012
Q3
2014
Q1
Q4
Q3
Q2
Q1
Q4
Revenue
$ 99,727
$ 101,093
$ 102,437
$ 104,803
$ 106,648
$ 107,552
GAAP operating earnings
Restructuring and employee severance
Amortization and other acquisition-related costs
Impairments and loss on disposal of assets
Litigation (recoveries)/charges, net
Other Spin-Off Costs
Non-GAAP operating earnings
$
$
$
$
$
$
(in millions)
GAAP operating earnings margin rate
Non-GAAP operating earnings m argin rate
3-year m argin expansion
$
1,011
76
179
859
(15)
2,109
$
1.01 %
2.11 %
64bp
996
71
158
859
(38)
2,046
0.99 %
2.02 %
$
1,842
48
117
29
(37)
1,999
1.80 %
1.95 %
$
1,893
22
37
25
(34)
1
1,943
1.81 %
1.85 %
$
1,836
23
34
21
(22)
1
1,893
1.72 %
1.77 %
$
1,792
21
33
21
(3)
2
1,866
1.67 %
1.73 %
2011
Q2
Q1
Q4
Q3
Q2
Q1
$ 107,551
$ 106,705
$ 104,999
$ 102,644
$ 100,340
$ 98,612
$ 98,160
$
$
$
$
$
$
$
$
1,747
17
37
20
(9)
4
1,816
1.62 %
1.69 %
$
1,668
16
94
7
(4)
4
1,786
1.56 %
1.67 %
$
1,562
17
106
8
2
8
1,703
1.49 %
1.62 %
$
1,514
16
90
9
6
10
1,644
1.48 %
1.60 %
$
1,489
17
86
9
(22)
9
1,588
1.48 %
1.58 %
$
1,408
25
58
9
(29)
12
1,483
1.43 %
1.50 %
$
1,431
33
28
7
(60)
12
1,451
1.46 %
1.48 %
The sum of the components may not equal the total due to rounding.
Forw ard-Looking Non-GAAP Financial Measures
We present non-GAAP earnings from continuing operations (and presentations derived from these financial measures, including per share calculations) on a forw ard-looking basis. The most directly comparable forw ard-looking GAAP
measures are earnings from continuing operations. We are unable to provide a quantitative reconciliation of these forw ard-looking non-GAAP measures to the most directly comparable forw ard-looking GAAP measures because w e
cannot reliably forecast restructuring and employee severance, amortiztion and other acquisition-related costs, impairments and loss on disposal of assets and litigation (recoveries)/charges, net, w hich are difficult to predict and
estimate and are primarily dependent on future events. Please note that the unavailable reconciling items could significantly impact our future financial results.
23
24. Cardinal Health, Inc. and Subsidiaries
GAAP / Non-GAAP Reconciliation
(in millions)
Revenue
$
GAAP operating earnings
Restructuring and employee severance
Amortization and other acquisition-related costs
Impairments and loss on disposal of assets
Litigation (recoveries)/charges, net
Other Spin-Off Costs
Non-GAAP operating earnings
$
GAAP operating earnings m argin rate
Non-GAAP operating earnings m argin rate
The sum of the components may not equal the total due to rounding.
24
Fiscal Year
2012
2011
2013
$
101,093
996
71
158
859
(38)
2,046
0.99 %
2.02 %
29bp
$
$
$
107,552
1,792
21
33
21
(3)
2
1,866
1.67 %
1.73 %
13bp
2010
$
102,644
$
$
1,514
15
90
9
6
10
1,644
$
$
1.48 %
1.60 %
18bp
$
98,503
1,307
91
18
29
(62)
11
1,394
1.33 %
1.42 %
25. Cardinal Health, Inc. and Subsidiaries
Definitions
Non-GAAP Diluted EPS from Continuing Operations and grow th rate calculation1: non-GAAP earnings from continuing operations divided by diluted w eighted-average shares
outstanding.
Non-GAAP Earnings from Continuing Operations: earnings from continuing operations excluding (1) restructuring and employee severance2, (2) amortization and other acquisitionrelated costs 3, (3) impairments and loss on disposal of assets 4, (4) litigation (recoveries)/charges, net5, (5) Other Spin-Off Costs and (6) gain on sale of CareFusion stock, each net of tax.
Non-GAAP Operating Earnings: operating earnings excluding (1) restructuring and employee severance, (2) amortization and other acquisition-related costs, (3) impairments and loss
on disposal of assets, (4) litigation (recoveries)/charges, net and (5) Other Spin-Off Costs.
Non-GAAP Operating Earnings Margin Rate: non-GAAP operating earnings divided by revenue.
Other Spin-Off Costs: costs incurred in connection w ith our Spin-Off of CareFusion w hich are included in distribution, selling, general and administrative expenses.
Segm ent Profit: segment revenue minus (segment cost of products sold and segment distribution, selling, general and administrative expenses).
Segm ent Profit from International6: international revenue minus (international cost of products sold and international distribution, selling, general and administrative expenses).
Segm ent Profit Margin: segment profit divided by segment revenue.
1
Except for compound annual grow th rates (CAGR), grow th rates in this presentation are determined by dividing the difference betw een current period results and prior period results by
prior period results. CAGR is determined by subtracting one from ((the ending value divided by the beginning value) raised to the pow er of (one divided by the number of years)).
2
Programs w hereby Cardinal Health fundamentally changes its operations such as closing and consolidating facilities, moving manufacturing of a product to another location, production or
business process sourcing, employee severance (including rationalizing headcount or other significant changes in personnel) and realigning operations (including substantial realignment
of the management structure of a business unit in response to changing market conditions).
3
Costs that consist primarily of amortization of acquisition-related intangible assets, transaction costs, integration costs and changes in the fair value of contingent consideration obligations.
4
Asset impairments and losses from the disposal of assets not eligible to be classified as discontinued operations are classified w ithin impairments and loss on disposal of assets w ithin the
consolidated statements of earnings.
5
Loss contingencies related to litigation and regulatory matters and income from favorable resolution of legal matters.
6
Includes CAH Puerto Rico and our non-U.S. operations.
25